Stereochemically Defined Polypropionates via Chiral Resolution

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing natural products and natural product-like libraries lack stereochemically defined polypropionates, which are essential for creating biologically active compounds with precise structural elements.

Innovation Solution

The development of stereochemically defined polypropionates, including pentads and tetrads, through specific methods involving the oxidation of enantiomerically pure compounds and the use of chiral amines for resolving diastereomeric salts, allowing for the preparation of compounds with precise stereochemistry.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional synthesis methods are used for natural products, then the synthesis process can proceed without specialized stereochemical reagents, but the resulting compounds lack precise stereochemical definition and biological activity

Engineering Contradiction:
Improvestereochemical precisionVSAvoidsynthesis method complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by pre-establishing stereochemical definition in the starting materials (enantiomerically pure compounds of Formulae 1A and 1B) before the main synthesis sequence. This allows subsequent reactions to proceed with inherent stereochemical control, achieving precise polypropionate tetrad and pentad structures without requiring complex stereochemical reagents at each step.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses diastereomeric salt formation as an intermediary step to resolve racemic mixtures into enantiomerically pure compounds. Chiral amines act as mediators that temporarily convert enantiomers into separable diastereomeric salts, enabling the isolation of single enantiomers that then serve as stereochemically defined starting materials for polypropionate synthesis.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If enantiomerically pure starting materials are used, then stereochemically defined polypropionates can be synthesized, but the preparation process becomes more complex involving resolution steps

Engineering Contradiction:
Improvestereochemical purityVSAvoidsynthesis ease
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent applies parameter changes by systematically varying reaction conditions during the resolution process, including solvent selection, temperature control, and pH adjustment, to optimize the formation and separation of diastereomeric salts. These parameter optimizations make the resolution process more efficient and easier to implement despite the additional steps required for achieving enantiomeric purity.

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If diastereomeric salt resolution is performed, then enantiomerically pure compounds can be obtained, but additional time and processing steps are required

Engineering Contradiction:
Improveenantiomeric purityVSAvoidresolution process time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent segments the overall synthesis process into distinct modular stages: (1) formation of diastereomeric salts from racemic mixtures, (2) separation of diastereomeric salts through crystallization or filtration, and (3) conversion of separated salts to enantiomerically pure compounds. This segmentation allows each step to be independently optimized and facilitates parallel processing where multiple resolutions can be conducted simultaneously.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the synthesis of biologically active compounds with precise structural elements, enhancing the potential for therapeutic applications by providing stereochemically pure polypropionates that can be used in preparing natural products and libraries.

Implementation Method 1

compounds of Formulas Ia and/or Ib are prepared by oxidizing a compound of Formula 1

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 2

the mixture of compounds of Formulas 1A and 1B can be obtained by forming a mixture of esters of Formulas 1A and 1B having free carboxylate groups, and then treating the mixture of esters of Formulas 1A and 1B having free carboxylate groups with a chiral amine-containing compound

Methodology Applied
Scientific EffectSalt formation: Chemical Bonding

Implementation Method 3

the resolution compounds of Formulas 1A and 1B can be achieved by selective crystallization and/or selective precipitation of a mixture of diastereomeric salts of Formulas 1A and 1B

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Implementation Method 4

the resolution compounds of Formulas 1A and 1B can be achieved by selective crystallization and/or selective precipitation of a mixture of diastereomeric salts of Formulas 1A and 1B

Methodology Applied
Scientific EffectPrecipitation: Precipitation

Data Source

PatentUS10793581B2Stereochemically defined polypropionates and methods for making and using the same
Publication Date: 2020.10.06 EISAI R&D MANAGEMENT CO LTD
  • US10793581B2 patent drawing
  • US10793581B2 patent drawing
  • US10793581B2 patent drawing

AI summary

The present invention relates to stereochemically defined polypropionates and methods for preparing and using the same. The stereochemically defined polypropionates may be useful in the synthesis of natural products and/or natural product-like libraries.